Novel Pulsatile Cardiac Assist Pump by Mohanadas, Lakshmi
Wayne State University
Wayne State University Theses
1-1-2015
Novel Pulsatile Cardiac Assist Pump
Lakshmi Mohanadas
Wayne State University,
Follow this and additional works at: http://digitalcommons.wayne.edu/oa_theses
Part of the Biomedical Engineering and Bioengineering Commons
This Open Access Thesis is brought to you for free and open access by DigitalCommons@WayneState. It has been accepted for inclusion in Wayne
State University Theses by an authorized administrator of DigitalCommons@WayneState.
Recommended Citation
Mohanadas, Lakshmi, "Novel Pulsatile Cardiac Assist Pump" (2015). Wayne State University Theses. Paper 409.
  
 
 
 
NOVEL PULSATILE CARDIAC ASSIST PUMP 
by 
LAKSHMI MOHANADAS 
THESIS 
Submitted to the Graduate School 
of Wayne State University, 
Detroit, Michigan 
in partial fulfillment of the requirements 
for the degree of 
MASTER OF SCIENCE 
2015 
MAJOR: BIOMEDICAL ENGINEERING 
Approved By: 
_______________________________________ 
Advisor                                                           Date 
 
  
ii 
 
 
DEDICATION 
 
 
 
 
To  
My Parents and friends 
 
 
 
 
 
 
 
 
 
  
iii 
 
ACKNOWLEDGEMENTS 
I owe a great thanks to a great many people who has helped, supported and 
encouraged me throughout this journey. My sincere gratitude to my advisor Dr. Auner for 
extending his constant interest, support, genuine apprehension and encouragement  for the 
success of this project. I would also like to thank Dr. Huang for rendering his technical 
support and helping  me in the construction of this study. His patience and scholarly 
knowledge made the work more enjoyable. Thanks are due to my  Department of Biomedical 
Engineering, Wayne State University for putting forward guidelines for the timely 
completion of the thesis.  
I also thank my committee members: Dr. M. Kavadia and Dr. M. Brusatori for 
their valuable time and readily accepting to participate in my thesis. 
I thank the Almighty, who is the source of this life and provided me with the 
strength, knowledge and wisdom. 
I render my regards to my beloved parents and friends for their untiring love 
and inspiration which helped me carry out my task.  
  
  
iv 
 
TABLE OF CONTENTS 
DEDICATION.........................................................................................................................ii 
ACKNOWLEDGEMENTS...................................................................................................iii 
LIST OF TABLES..................................................................................................................vi 
LIST OF FIGURES...............................................................................................................vii 
1. Introduction..........................................................................................................................1 
   1.1. Need for improved design..............................................................................................17 
2. Blood Rheology..................................................................................................................19 
   2.1. Blood behavior...............................................................................................................19 
   2.2  Newtonian and non-Newtonian fluid.............................................................................20 
   2.3  Blood components.........................................................................................................23 
       2.3.1  Blood plasma..........................................................................................................23 
       2.3.2  RBC aggregation and deformation.........................................................................23 
       2.3.3 Hematocrit................................................................................................................25 
       2.3.4  Fibrinogen...............................................................................................................26 
       2.3.5  Temperature............................................................................................................26 
       2.3.6  WBC and platelets..................................................................................................27 
  
v 
 
       2.3.7  Thrombosis.............................................................................................................27 
   2.4. Effect of fluid mechanics on pump development..........................................................27 
3. Design Principle and Working..........................................................................................29 
   3.1.  Design...........................................................................................................................29 
   3.2.  Principle........................................................................................................................32 
   3.3.  Working mechanism.....................................................................................................34 
   3.4.  Simulation.....................................................................................................................35 
4. Materials Used....................................................................................................................40 
   4.1.  Chemical background and uses.....................................................................................40 
   4.2.  Basic properties.............................................................................................................40 
   4.3.  LSR usage in laboratory................................................................................................41 
5. Discussion and Conclusion................................................................................................43 
Appendix 1..............................................................................................................................45 
Appendix 2..............................................................................................................................48 
References...............................................................................................................................69 
Abstract...................................................................................................................................71 
Autobiographical Statement.................................................................................................73  
  
vi 
 
LIST OF TABLES 
Table 1.  Axial blood pumps.....................................................................................................6 
Table 2.  Centrifugal pumps......................................................................................................7 
Table 3.  Diagonal pumps.........................................................................................................8  
Table 4.  Detailed description of different types of axial pumps..............................................9 
Table 5.  Detailed description of different types of centrifugal pumps...................................11 
Table 6.  Detailed description of different types of diagonal pumps......................................16 
Table 7.  Set of constants used for modeling..........................................................................27 
 
 
 
 
 
  
  
vii 
 
LIST OF FIGURES 
Figure 1. Type of blood pumps.................................................................................................4 
Figure 2.  Types of rotary pumps in the market .......................................................................5 
Figure 3.  Shear stress and shear rate relationship in Newtonian and non- Newtonian  
fluids........................................................................................................................................21 
Figure 4.  Non- Newtonian shear stress and shear strain along with  
Casson's Plot............................................................................................................................23 
Figure 5.  Relationship between the viscosity of blood and the shear  
rate............................................................................................................................................24 
Figure 6.  Graph showing relationship between blood viscosity and 
hematocrit value.......................................................................................................................25 
Figure 7.  Front view of the proposed pump...........................................................................29 
Figure 8.  Side views of the pump design...............................................................................30 
Figure 9.  Three dimensional model of the proposed pump...................................................31 
Figure 10. The two dimensional cut section...........................................................................31 
Figure 11.  Layer section of the pump....................................................................................32 
Figure 12.  Proposed positioning of the pump in development..............................................33 
  
viii 
 
Figure 13.  A  pneumatic version of the pumping apprentice.................................................35  
Figure 14.  Geometric model construction..............................................................................36 
Figure 15.  End result of simulation depicting the load applied...........................................38 
Figure 16.  Packed Liquid silicone rubber as Part A and Part B.............................................41 
Figure 17.  The two inner surface moulds made out of LSR..................................................42 
 
 
 
  
1 
 
 
 
CHAPTER 1 
INTRODUCTION 
 
Cardiac pumps are revolutionary devices which assist the failing heart 
function. Over the decade many cardiovascular pumps have been developed  to assist the 
heart. These devices are generally mechanical pumps which help in efficient blood 
circulation. Due to the increase of cardiac complications after a surgery and the number of 
patients suffering from heart functioning problems, the demand of heart assistive pumps has 
also increased in the market which can efficiently increase the heart functioning rate and 
there by enhance the patient's condition. There are two types of patients who generally need 
the use of a pump to support the function of their heart. One, those who need immediate 
assistance after an heart attack or a heart surgery and two, those who are waiting for a heart 
transplant and they have long wait time. This wait time till transplantation is called as bridge 
to transplantation.  Sometimes these pumps are also used as end therapy, that is the pump is 
used to provide good quality of life till the recovery of the patient and no transplantation 
occurs. This usage is also known as bridge to recovery.  
In general, the blood pumps are classified on the basis of their mechanical 
action. The two such categories are: displacement pump and rotary pump [1]. Displacement 
pumps work on the basis of energy transfer due to periodic changes whereas a rotary pump 
changes the velocity of the impeller vanes. Rotary pumps become more advantageous over 
displacement pumps when large volume flow at low pressure is required. But when the low 
volumetric flow is required with high pressure, displacement pumps are preferred. 
Displacement pumps are vastly used in the medical field over the past decades for 
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cardiopulmonary bypass in heart lung machines and in the dialysis machines. These pumps 
have been widely in use due to their simplicity and low cost. But the major disadvantage 
caused by them is blood damage and particulate spallation. 
On the contrary rotary pumps are more advantageous over the displacement 
pumps as they possess less blood damage, smaller in size, better transportability, and absence 
of spallation. Due to all these advantages over displacement pumps, centrifugal pumps, a 
type of rotary pump, is gaining lot of market in the cardiopulmonary bypass application. But 
due to the use of rollers, these can be used upto a time limit of 4 hours as there is risk of 
blood cell damage and to compensate high doses of anticoagulation drugs are also used. 
These are used to assist patients after an open heart surgery who suffers from low cardiac 
output known as low output syndrome (LOS) but fails to do so. Hence in treatment more of 
inotropic and vasoactive drugs are used. 
A number of different types of rotary and displacement pumps are still used as 
ventricular support system.  Micro-axial pump is one such type from rotary pumps group 
which are introduce through femoral artery and its inflow cannula is place through the aortic 
valve to the left ventricle. The first axial-type blood pump was introduced into the market by 
Johnson & Johnson (Division of Ethicon Inc., Arlington, TX, USA) under the name of 
‘Hemopump’[1].   
Another type is the pneumatic displacement pump which is introduced 
through thoracotomy. These pumps possess the risk of skin infection at their penetration 
sites. Also the patient has less mobility due to the bulkiness and the moving consoles. To 
compensate old mechanical support systems, fully implantable electro-mechanical left 
ventricular assist devices (LVADs) have been developed. Two such systems that are 
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currently available are the NOVACOR (Baxter Healthcare Corp., Deerfield, IL, USA)[3][4] 
and the HeartMate (Thermo Cardiosystems Inc., Woburn, MA, USA)[5].   
Rotary pumps are classified generally into three categories according to the 
impeller geometry: Radial (centrifugal), axial and diagonal. Axial flow pumps are efficient at 
low pressure differences and generate high volumetric flow whereas a radial pump is 
designed to produce low flow rates at high pressure. Diagonal pumps also known as mixed 
flow systems, generally operate at high pressure to provide high flow rate.  
As stated rotary pumps have a number of theoretical and practical advantages 
over the displacement types. They have low blood trauma, lesser anti coagulation levels and 
therefore lesser chances of hemorrhage. Also depending on the design, they can also be 
coated with heparin. A detailed tree chart description of different types of pumps available in 
the market is provided in figure 1 and figure 2 [1]. A further more detailed description of the 
devices in the market is given in tables 1,2,3 and 4. These tables shows the description of the 
pumps mentioned in the figure 1 and 2. The pump name and the company which prototyped 
it along with the application, the position of the pump, what type of support does the pump 
offer and for what duration the pump is used is provided in the table. Table 2 specifically 
enumerates the different types of centrifugal pumps in the market with their developers and 
the duration for which they are used. 
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Fig 1:  Type of Blood pumps [1] 
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Fig 2: Types of Rotary Pumps in the market 
 
 
 
 
ROTARY BLOOD PUMPS 
Axial Pumps
Hemopump
Sun Waseda
(IVAP)
HeartMate II
Valvo Pump
Jarvik 2000
DeBakey
Impella
Streamliner
Radial Pumps
Biopump
Delphin
Rotodynamic 
Pump
Rota Flow
Nikkisso Pump
Vienna 
Centrifugal
Abiomed CF
MSCP
Capiox SP
Isoflow
(Lifestream)
Gyro Pump
HiFlow
AB-180
Evaheart
Kriton Pump
Heart Mate III
Diagonal Pumps
VentrAssist
Delta Stream 
Heart Quest
HIA Micro 
Diagonal
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Table 1: Axial Blood Pumps [1] 
Pump Organization Application Position Support Duration 
Hemopump 
 
 
Medtronic 
Inc., 
Minneapolis, 
MN, USA 
 
Postcardiotomy/ 
coronary 
surgery 
 
Implantable 
intra-arterial/ 
transvalvular 
(aortic valve)  
Left 
ventricular 
 
 
Short 
term/ 
medium 
term 
 
Jarvik 2000  
Jarvik Heart 
Inc., Oxford 
Heart Centre, 
USA/UK 
VAD/BTT Implantable intraventricular 
Left 
ventricular  Long term  
IVAP 
Sun Medical 
Co., Waseda 
University, 
Tokyo, Japan 
VAD/BTT Implantable 
intraventricular 
Left 
ventricular 
Long term 
DeBakey 
VAD 
MicroMed 
Technology 
Inc., Texas, 
USA 
VAD/BTT 
Fully 
implantable 
abdominal 
Left 
ventricular 
Long term 
HeartMate 
II 
TCI/Nimbus 
Inc./ Pittsburgh 
University, 
Pennsylvania 
USA 
VAD/BTT Implantable 
abdominal 
Left/right 
ventricular 
Long term 
Impella 
Impella, 
Cardiotechnik 
AG Aachen, 
Germany 
Minimal 
invasive 
heart 
surgery 
Fully 
implantable 
intraventricular 
Left/right 
ventricular 
Short term 
(< 6 h) 
Valvo 
Pump 
Keio University, 
Hokkaido 
University, 
Tokyo, Japan 
VAD/similar 
to valve 
replacement 
Implantable 
transvalvular 
Left/right 
ventricular 
Medium 
term 
Streamliner 
McGowan 
Center, 
Pittsburgh 
University, 
Pennsylvania 
USA 
VAD/BTT 
Implantable 
abdominal 
Left/right 
ventricular 
Long term 
VAD: Ventricular Assist Device; BTT: Bridge to transplant 
 
 
7 
 
 
 
Table 2: Centrifugal pumps [1] 
Pump Organization Application Position Support Duration 
Bio-Pump 
Medtronic 
Biomedicus 
Inc., 
Minneapolis, 
MN, USA 
Postcardiotomy/ 
CPB Extracorporeal 
Left/right 
ventricular 
Short 
term 
Capiox 
Terumo 
Corporation 
Tokyo, Japan 
CPB/postcardiotomy Extracorporeal Left/right ventricular 
Short 
term 
Sarns 
Delphin 
Sarns/3M 
Health Care, 
Ann Arbor, MI, 
USA 
Postcardiotomy Extracorporeal Left/right ventricular 
Short 
term 
Isoflow 
(Lifestream) 
Bard 
Cardiopulmonar
y Products/St 
Jude  Medical 
Inc., Haverhill, 
CPB Extracorporeal Left/right ventricular 
Short 
term 
RotaFlow 
JOSTRA 
Medizintechnik 
AG Hirrlingen, 
Germany 
CPB/postcardiotomy Extracorporeal Left/right ventricular 
Short 
term 
Nikkiso Nikkiso Co. Ltd Tokyo, Japan CPB Paracorporeal 
Left/right 
ventricular 
Short 
term 
HiFlow 
HIA/Medos, 
GmbH 
Aachen, 
Germany 
CPB/postcardiotomy Extracorporeal 
Left/right 
ventricular 
Short 
term 
Rotodynamic 
Cleveland 
Clinic 
Foundation, 
OH, USA 
VAD Implantable 
Left/right 
ventricular 
Long 
term 
Gyro 
Baylor College 
of Medicine, 
Houston, TX, 
USA 
VAD /CPB Implantable/ paracorporeal 
Left/right 
ventricular 
Long 
term to 
Medium 
term 
AB-180 
Cardiac Assist 
Technologies 
Inc. 
Pittsburgh, 
PA, USA 
VAD postcardiotomy 
Implantable/ 
Thoracic 
cavity 
Left 
ventricular 
Short 
term 
Medium 
term 
Vienna 
Vienna 
University 
Vienna, Austria 
VAD Implantable/ thoracic cavity 
Left/right 
ventricular 
Long 
term 
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Evaheart 
Sun Medical 
Corp Pittsburgh 
University 
Japan/USA 
VAD 
BTT 
Implantable/ 
thoracic cavity 
Left 
ventricular 
Long 
term 
Abiomed 
CF 
Abiomed Inc., 
Danvers, MA, 
USA 
VAD Implantable Left/right ventricular 
Long 
term 
Kriton 
Kriton Medical 
Inc., Citrus 
Heights, CA, 
USA. 
VAD 
Implantable/ 
left ventricular 
apex 
Left 
ventricular 
Long 
term 
MSCP 
Terumo 
Corporation 
Setsunan 
University 
Japan 
VAD Implantable/ thoracic cavity 
Left 
ventricular 
Long 
term 
 
Table: 3 Diagonal pumps[1] 
Pump Organization Application Position Support Duration 
VentrAssist 
Micromedical 
Ltd, Sydney 
University, 
Australia 
VAD/ BTT Implantable/ abdominal 
Left/right 
ventricular Long term 
HeartQuest 
MedQuest 
Products Inc., 
Salt Lake City, 
UT, USA. 
VAD/ TAH 
Implantable/ 
Abdominal 
Left/right 
ventricular 
Long term 
(> 10 
years) 
DeltaStream 
HIA/Medos, 
GmbH 
Aachen, 
Germany 
CPB/VAD/ 
ECMO, etc. 
Extracorporeal Left/right ventricular Short term 
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Table 4 : Detailed description of different types of axial pumps [1] 
PUMP 
WEIGHT/
SIZE 
FLO
W 
RAT
E 
(L/M
IN) 
ROTATI
ONAL 
SPEED 
(RPM) 
POW
ER 
REQ 
(WAT
TS) 
TYPES 
OF 
BEARI
NGS 
TYPE
S OF 
SEALS 
TYPES 
OF 
SENSOR
S 
ADDITIO
NAL 
FEATUR
ES 
STAGE OF 
DEVELOP
MENT 
Hemopump 
 
6g/5cc 4.5 25000 70 Purge 
fluid - 
lubricate
d 
hydrostat
ic journal 
bearings 
Purged 
seal 
system 
Dextros
e 
solutio
n as 
purge 
fluid 
External 
controller 
in console 
Impeller 
(Archimed
es screw) 
is driven 
by a 
flexible 
cable, 
which is 
rotated by 
a 
paracorpor
eal motor 
 
Pump 
introduced 
through 
femoral 
artery 
 
Applicatio
n in 
minimal 
invasive 
heart 
surgery 
 
Not 
produced 
anymore 
Clinical use 
(since 1990) 
Jarvik 2000 
 
 
90g/25cc 6 10000-
160000 
7-10 Blood- 
immerse
d 
ceramic 
bearings 
No 
seals 
External 
microproc
essor- 
based 
automatic 
motor 
controller 
regulating 
pump 
speed 
according 
to 
physical 
demands 
Control 
modes: 
Heart rate 
responsive 
mode or 
fixed rate 
mode 
possible 
Rotor 
magnets 
inside 
impeller 
 
Electrical 
wires 
penetrate 
scalp 
 
Pediatric 
type 
available 
Animal 
experiments 
 
 
 
IVAP 170 g 5 9 8 Pressure- 
grooved 
ceramic 
journal 
bearings 
Bearings 
First: 
purged 
- lip 
seal 
(silicon
e) 
External 
blood 
pump 
controller 
Pump 
introduced 
through 
LV apex, 
outflow 
across 
Animal expt 
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cooled 
by purge 
fluid 
Bearings 
acting as 
a 
miniatur
e viscous 
pump for 
the purge 
fluid 
(spiral/ 
helix 
grooves 
on 
bearings 
surface) 
 
Later: 
Cool 
seal 
system 
aortic 
valve 
DeBakye VAD 
 
95g/ 15cc 5 7500-
120000 
6 Ceramic 
bearings 
(blood 
lubricate
d) 
located 
as the 
conjuncti
on of the 
impeller 
with the 
flow 
straighte
ner 
(front) 
and flow 
diffuser 
(rare) 
No 
seals 
Micro- 
controller 
coupled 
with 
internal 
battery 
powered 
by TETS 
Rotor 
magnets 
are located 
(hermetica
lly sealed) 
inside the 
impeller 
vanes 
CFD -
based 
design 
Prices < 
USD 
10000 
Clinical trial 
HeartMate II 
 
160g/62cc 6 6000-
13000 
10 Ceramic 
bearings, 
similar to 
ball cup 
jewel 
bearings, 
acting 
against 
radial 
and axial 
thrust 
Blood 
immerse
d 
Ceramics 
and 
diamond 
coatings 
preferred 
bearing 
materials 
No 
seals 
Electronic
( external) 
controller 
modulates 
pump 
speed 
according 
to 
physiologi
cal 
demands 
Rotor 
magnets 
are located 
in the hub 
of the 
pumps 
rotor 
 
TETS will 
be used in 
the future 
Ready for 
clinical trial 
Impella 
 
5g/2cc 4.5 30000 12 Ball 
bearings 
located 
inside 
motor 
chamber 
Polyme
ric lip 
seal 
Internal 
pressure 
sensors 
for 
monitorin
g, external 
controller 
integrade 
in console 
Pump 
introduced 
through 
the 
femoral 
artery 
 
Integrated 
electric 
motor 
 
Long-term 
pump in 
developme
Clinical use 
11 
 
 
 
nt 
Price < US 
$1000 
Valvo Pump 
 
138g/40cc 5 9000 26 Miniatur
e ball 
bearings 
Ferrofl
uidic 
shaft 
seal 
 
Seal 
ring: 
Nd-Fe-
B 
magnet 
 
Ferrofl
uid: 
ferricol
loid 
HC-50 
Motor 
speed is 
determine
d by 
counting 
pulses 
from the 
Hall 
sensors in 
the motor 
Myocardiu
m is used 
as pump 
housing 
 
Pump may 
also be 
used in 
grafts 
 
Motor 
shaft is 
glued to 
the rotor 
Laboratory 
Streamliner 
 
    Magnetic
ally 
levitated 
bearings 
 
Conical 
in shape 
 
Blood 
lubricate
d and 
biocomp
atible 
bearings 
No 
seals 
Internal 
and 
external 
controller 
coupled 
with 
TETS 
 
Hybrid 
controller 
architectur
e 
Computati
onally 
optimized 
impeller 
geometry 
 
CFD-
based 
design 
Laboratory 
 
 
Table 5: Detailed description of different types of centrifugal pumps [1] 
PUMP WEIGH
T/SIZE 
FLO
W 
RAT
E 
(L/M
IN) 
ROTATI
ONAL 
SPEED 
 (RPM) 
POW
ER 
REQ 
(WA
TTS) 
TYPES OF 
BEARINGS 
TYPES OF 
SEALS 
TYPES OF 
SENSORS 
ADDITION
AL 
FEATURE
S 
STAGE 
OF 
DEVELO
PMENT 
Bio- Pump 
 
200g/87c
c 
6 5 8 Polycarbonate 
journal bearing 
Flexible 
polymeric  
seal 
Bio-console: 
electromagn
etic flow 
measurement 
and pump 
speed 
controller  
Rotating 
cone type 
pump 
 
Constraint 
force Vortex 
pump 
 
Bioactive 
surface 
available for 
improved 
biocompatibi
lity  
 
BP- AT: 
Adult 
biopump 
BP50 
pediatric 
biopump 
Frequently 
Clinical 
use 
(greater 
than 20 
years) 
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used as 
reference 
pump for 
comparison 
studies 
Capiox 
 
46cc 5 3000  Ball bearings  Polymeric 
lip seal 
Auto flow 
cruise 
control 
system 
adjusts 
rotational 
speed to 
desired  flow 
rate 
 
Ultrasonic 
Doppler 
flow meter.  
Straight-path 
Rotor 
reduces 
pump speed 
without the 
decreasing 
hydraulic 
efficiency 
resulting in 
less 
hemolysis 
 
Rotor 
powered by 
magnetic 
coupling 
 
Automatic 
priming 
function 
allows 
pulsatile 
flow mode 
Clinical 
use 
Sarns 
Delphin 
 
130g 9 3600  Ball bearings Polymeric 
lip seal 
 
Problems 
with seal 
disruption 
encountered 
in clinical 
use 
Microcompu
ter-based 
control 
console 
 
Doppler 
flow sensor 
 
Pulsatile 
flow mode 
option 
 
Open 
impeller 
with straight 
vanes 
 
 
Activated by 
magnetic 
coupling  
Clinical 
use 
(greater 
than 10 
years) 
 
Isoflow 
 
290g 9 3500  Sleeve 
bearings 
(sintered slide 
bearings) and 
ball bearings 
(axial thrust 
bearing) 
Lip seal Microproces
sor-based 
system 
controller 
 
Reusable 
ultrasonic 
flow rate 
sensor 
Open 
impeller 
with curved 
vanes  
 
Activated by 
magnetic 
coupling 
Clinical 
use (> 10 
years) 
RotaFlow 
 
35cc 10 4000  Magnetic 
stabilized rotor 
bearing (radial 
magnetic 
suspension)  
 
Low friction 
blood-
immersed 
pivot bearing -
-- sapphire ball 
(Al2O3) and 
polyethylene 
calotte without 
shaft seals 
No seals Flow and 
bubble 
sensors in 
drive unit, 
pressure 
transducers 
 
Stand-alone 
console 
Rotor 
powered by 
radial 
magnetic 
coupling 
 
Logarithmic 
spiral 
channels  
Clinical 
use 
Nikkiso 145g/25c
c 
10 36000 15 Ball bearings  V-shaped 
ring seal 
made of 
flurorubber  
Ultrasonic 
flow meter 
 
External 
console 
Activated by 
magnetic 
coupling 
 
Rotor driven 
Clinical 
use 
13 
 
 
 
 
by console 
through 
flexible shaft  
 
CFD studies 
on hemolysis 
 
Six straight 
vanes, six 
washout 
holes  
 
Two week 
with purging 
system 
washing the 
shaft-seal 
area 
 
Joint 
venture: 
Baylor 
College of 
Medicine 
has lead to 
Gyropump 
HiFlow 
 
90g/30cc 6 3500 25 Spherical 
blood-
immersed rotor 
thrust bearing . 
Ceramic-
polymer 
bearing 
Minimal 
contact radius 
reduces heat 
generation 
within the 
bearing area 
No seals Pressure 
transducer 
and flow 
probe 
Activated by 
magnetic 
coupling 
 
Pulsatile 
pumping 
option  
Laboratory 
Rotodynamic 
 
207g/62c
c 
5 3000 6-7 Blood-
lubricated 
hydrodynamic 
journal 
bearings 
 
Magnetic 
attraction 
between stator- 
rotor acts as 
thrust bearing 
No seals Flow rate 
proportional 
to heart rate 
determined 
by 
pacemaker 
Grooved 
bearing 
surface 
provides a 
self-
pumping 
action that 
generates 
wash flow 
 
Motor is 
surrounded 
by cooling 
blood flow 
 
TETS used 
for energy 
supply 
Laboratory 
14 
 
 
 
Gyro 
 
305g/145
cc 
10 26000 7 Duoble pivot 
bearing system 
at top and 
bottom of 
impeller 
Blood-
immersed 
bearings 
 
Alumina 
ceramic(Al2O3
) male pivot 
and 
polyethylene 
(UHMWPE) 
female pivot 
No seals Actuator 
controller 
Eccentric  
inlet port 
eliminates 
obstacles in 
the blood 
path  
 
Activated by 
magnetic 
coupling 
 
GyroPI: 
Implantable- 
VAD 
GyroC1E3: 
Paracorporea
l-CPB 
Animal 
Expt 
AB-180 
 
284g/44c 6 4500 4 Bearings 
hydrodynamic 
journal bearing 
made of 
polycarbonate 
 
Lubricated and 
cooled by 
sterile water/ 
heparin 
infusion 
Polyurethane
- coated 
rubber seal 
Microproces
sor-based 
device 
regulates 
pump speed, 
infusion rate 
and occluder 
safety 
system 
Balloon 
occluder 
system: 
Prevents 
back flow 
from aorta to 
let atrium if 
the pump 
fails 
 
Heparin 
infusion also 
used for 
anti-
coagulation 
 
Rotor is 
powered by 
electromagn
etic coupling 
Clinical 
use 
Vienna 
 
240g/101
cc 
6 2.5 15 Hybrid 
mechanical-
magnetic 
bearing system 
(permanent 
magnets) 
 
Single mono-
pivot 
mechanical 
support 
(ceramic/polye
thylene) 
No seal/shaft Various 
controllers 
tested: Fuzzy 
non-linear 
and neuronal 
Activated by 
magnetic 
coupling 
using 
double-disk 
motor 
 
Magnets 
used both for 
driving and 
bearing 
Animal 
Expt 
Evaheart 
 
280g/150
cc 
7 2500 9-10 Hydro 
dynamic 
journal bearing 
made of SiC  
 
Lubricated and 
cooled by 
purge fluid 
(sterile pure 
water)  
 
Viscous 
pumping effect 
by spiral 
grooves on 
bearing surface 
Cool seal 
system: 
mechanical 
seal with 
circulating 
purge fluid 
Ultrasonic 
flow 
measurement  
 
Thermocoup
le meter for 
purge fluid 
temperature 
Purge fluid 
continuously 
purified and 
sterilized by 
ultra 
filtration  
 
Diamond-
like carbon 
coating  
Animal 
Expt 
Abiomed CF 190cc 10 3500 25 
(15 
for 
beari
Active 
magnetic 
suspension in 
combination 
No 
seals/shafts 
Analog 
electronic 
feedback 
control 
Activated by 
magnetic 
coupling 
using an 
Laboratory 
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ngs) with 
hydrostatic 
stabilization 
 
Electromagnet
s as actuators  
 
Fluid between 
rotor and 
housing 
stabilize the 
magnetic 
suspension and 
contain axial 
motion  
system for 
radial 
position 
 
Proximity 
sensors 
internal 
motor 
 
More 
compact and 
efficient 
system in 
future design 
Kriton 
 
195g/43c
c 
6 5000 6-10 Passive radial 
magnetic 
bearing acting 
in synergy 
with blood-
lubricated 
hydrodynamic 
bearings 
eliminating the 
need for 
proximity 
sensors 
 
Blood-
lubricated 
pivot bearing 
to constrain 
axial motion 
No seals Pressure 
meter and 
transonic 
flow probes  
Activated by 
magnetic 
coupling  
 
Thick-bladed 
impeller due 
to imbedding 
of rotor 
magnets 
within the 
impeller 
blades 
Laboratory  
MSCP 
 
400g/196
cc 
5 2 15 (9 
for 
magn
etic 
suspe
nsion
) 
Magnetic 
bearing  
 
Magnetic 
suspension of 
impeller 
providing 
contact free 
rotation 
 
Stainless steel 
motor bearings 
No 
seals/shaft 
Position 
sensors for 
magnetic 
suspension 
of bearings 
 
Sensor less 
system: No 
need for a 
flow pro, 
flow rate 
obtained 
through 
motor 
current 
Activated by 
magnetic 
coupling 
 
Extracorpore
al device 
available  
 
Future 
design: 
TETS, 
pulsatile 
mode, 
implantable 
controller  
Animal 
Expt 
  
16 
 
 
 
Table 6: Detailed description of different types of Diagonal pumps [1] 
PUMP 
WEIGH
T/SIZE 
FL
OW 
RA
TE 
(L/
MI
N) 
ROTATI
ONAL 
SPEED 
(RPM) 
PO
WE
R 
REQ 
(WA
TTS) 
TYPES OF 
BEARINGS 
TYPES 
OF 
SEALS 
TYPES OF 
SENSORS 
ADDITI
ONAL 
FEATUR
ES 
STAGE 
OF 
DEVELO
PMENT 
VentrAssist  
 
    Magnetic 
suspension 
coupled with 
hydrodynamic 
bearing 
 
Fixed permanent 
magnets in upper 
and lower housing  
 
Passively 
suspended rotor  
No seals  External 
controller 
worn on belt 
 
Sensor less 
motor 
control  
Diagonal 
flow 
impeller 
activated 
by 
magnetic 
coupling 
 
CAD and 
CFD 
optimized 
system 
 
Vacuum- 
deposited 
coatings  
Laboratory 
HeartQuest 
 
600g/275
cc 
10 2500 6.5 
for 
beari
ngs 
Hybrid magnetic 
bearing: actuators 
are a combination 
of permanent 
magnets and 
electromagnets 
(reduced power 
consumption) 
 
Full magnetic 
suspension  
No 
seals/shaf
t  
Sensor less 
system, 
controller 
monitors 
motor 
current and 
determines 
pump speed 
 
Position 
sensors for 
bearings  
Mixed 
flow 
impeller  
 
Motor 
integrated 
into the 
pump 
impeller 
and stator 
 
QuestCoat
: flexible 
ceramic 
coating  
Laboratory 
DeltaStream  
 
300g/150
cc 
8 9000 40 Ball bearings 
located inside the 
motor chamber  
Lip seal 
(polyuret
hane)  
Ultrasonic 
flow probe 
 
Hall sensor 
for motor 
speed 
 
Humidity 
sensor 
inside motor 
 
Temperature 
sensor on 
motor 
housing 
 
External 
console  
Pulsatile 
flow 
option 
 
CFD 
studies 
 
Highly 
integrated 
design  
Animal 
Expt 
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Table 1 is the list of axial pumps available in the market where as table 3 describes three type 
of diagonal pumps that are available with their developers name. The axial blood pumps, 
centrifugal and diagonal pumps further charted into a table with more detailed format of their 
power requirements, type of sensors, rotational speed etc. This table of detailed data can be 
referred from tables 4, 5 and 6 [1] and can be used as literary reference for the study of 
different axial and centrifugal pumps. 
1.1. Need for improved design: 
With all the technological advance and availability of different tools for 
proper pump design, it is still important to build, test and then improve any design. Due to 
variable nature of the blood, it is very essential to build and test the pump design accurately. 
Despite of all these, rotary pumps have their own hazards such as shear rate compensation. 
Rotary pumps are best to obtain high flow rates, nearly 20L/min [1] but despite of all 
advantages, these pumps has limitations over the cavitations threshold and maximum 
allowable shear rates. 
Hemolysis and platelet activation are affected by both shear stress and 
transition time in the pump [2]. In addition, blood trauma and blood cell destruction are most 
common. During the sealing, the heat generation also leads to local thrombus formation. 
These factors increase the risk of patient’s life and also call for the need of technical 
solutions with improved quality of life.  One of the major causes of death in USA is the Low 
output syndrome (LOS) after an open heart surgery. In addition to post- operational low 
output, cardiogenic shock or cardiac fibrillation also demands for more efficient means of 
cardiac assistive devices. 
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To avoid and reduce these causes due to traditional pumps, a pulsatile- 
continuous flow pump design is considered [13]. The main aim of the pump is to provide a 
20% cardiac assist to a person with congestive heart failures and other cardiac diseases. The 
pump under development is designed by utilizing a unique geometry and pumping actuation 
mechanism which helps to maintain low blood trauma, low anticoagulation levels preventing 
thrombosis and thus, less hemorrhage  chances. This design also uses polyethylene oxide 
(PEO), a biocompatible material, which minimizes the protein interaction with the interior 
pumping surface thus reduces the coagulation of blood due to interaction. 
The design utilizes biocompatible material, Polyethylene oxide (PEO), which 
minimized protein interaction with the interior pumping surface. Shape memory alloy 
actuators compress the pumping chamber. Shape memory alloy actuators also actuate 
compression of the ingoing sphincter valve and outgoing sphincter valves. Pumping motion 
can be analyzed by accelerometers to provide optimized feedback and pump motion control. 
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CHAPTER 2 
BLOOD RHEOLOGY 
The main concern of the project is to develop a design which can overcome 
the problems caused by the conventional pumps in the market. One of such problems is the 
hemolysis: the destruction of red blood cells causing the release of hemoglobin to the blood 
plasma. Hemolysis leads to platelet activation and thereby results in blood coagulation. 
Device induced platelet activation also leads to the consumption of anticoagulant drugs by 
the patient which over a period can cause internal bleeding. To help build an efficient design, 
one has to understand the fluid properties of blood. 
When compared to water, blood is acts as a non-Newtonian fluid. The study 
of blood fluid dynamics has been carried out from a very long period to better understand the 
flow in arterial, venal and extracorporeal systems. Extensive study of the flow pattern and 
deformation of blood components is known as rheology.  The deformation in case of blood 
refers to the viscoelastic behavior of blood. 
As described earlier in chapter 1, most of the disadvantages of the current 
pumps lies in the vast abnormality of blood pattern. To get a pump to work without major 
drawbacks, one has to understand the components involved in the blood flow dynamics. The 
major factors affecting are blood plasma viscosity, RBCs (Red Blood Cells), WBCs (White 
Blood Cells), platelets, the hematocrit value of blood, fibrinogen and temperature. 
 
2.1. Blood behavoir: 
Two study the fluid flow pattern of a blood we have to first understand the 
two main groups of liquid which are classified on the basis of viscosity and shear rate or 
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shear stress. First is Newtonian fluids in which viscosity is independent of the shear rate. 
Second is the non-Newtonian fluid in which viscosity may increase or decrease based on the 
shear rate. The magnitude of viscosity is calculated as the ratio of shear rate to shear stress. 
Shear stress is defined as the ratio of shear force to area. 
Shear stress  Ƭ = F/A (dyne/cm2) 
In the study of fluid mechanics for a pipe with constant diameter and length, 
the resistance to flow depends on the flow conditions within the pipe. If the flow of fluid is 
slow then the pressure drop is proportional to the flow velocity. In this case the fluid particles 
move smoothly and parallel to the tube wall. Such a type of flow is called as laminar flow. 
On the contrary when the pressure drop in the tube is proportional to the square of the flow 
speed then the flow pattern is called turbulent which is a more chaotic form of flow. The 
resistance to flow is more in turbulent pattern when compared with the laminar flow. 
 
2.2. Newtonian and non- Newtonian Fluid: 
As discussed earlier Newtonian and non-Newtonian fluids are the two 
classification of fluids which are based on the independency and dependency of viscosity on 
shear stress and shear rate respectively. In non-Newtonian fluids, the viscosity either 
increases or decreases with the increase in shear rate. As shown in figure 3 for Newtonian 
fluid, the slope of a shear stress versus shear rate graph gives a constant viscosity whereas for 
non-Newtonian fluid it varies along the graph. Non-Newtonian fluids have yield stress below 
which the shear stress is finite and the shear rate is zero giving an infinite viscosity condition.  
In case of blood if the yield stress is exceeded then the deformation of blood cells is 
irreversible leading to thrombosis. 
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Figure 3: Shear stress and shear rate relationship in Newtonian and non-Newtonian fluids 
If the viscosity decreases with increase in shear rate, then the fluid is called 
shear-thinning fluid and if the viscosity increases with the increase in shear rate then it is 
called shear- thickening. Human blood behaves as a shear-thinning fluid with viscosity 
varying between 4 to 5 centipoise (cP) at 37oC when observed at high shear rate of 100 to 
200 sec-1. With further increase in shear rate, viscosity becomes insensitive to shear rate.  
When the shear rate is reduced below 100 sec-1, viscosity increases exponentially with 
decrease in the shear rate. 
The coefficient of viscosity, ƞ,  in fluid mechanics is given by the ratio of 
shear stress Ƭ to shear strain rate γ̇ (also called velocity gradient): 
ƞ = Ƭ/ γ̇ (dynes-sec)/cm2(poise) 
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The steady state laminar flow can be given by Poiseuille's equation for a 
straight cylindrical tube:  
Q = π * ∆P* R4 / L * 8ƞ  where Q is the flow rate, ∆P is pressure difference, L 
is the length of the tube , R is the inner radius of the tube. This equation leads to the 
conclusion that for Newtonian fluids if the viscosity is doubled, the flow rate can be reduced 
to half and if the radius of the tube is doubled, it will lead to a 16 fold increase in the flow 
rate. 
To experimentally measure the fluid viscosity of Newtonian fluids capillary 
viscometer is used, whereas to measure non-Newtonian fluid this instrument is not enough. 
Hence Couette viscometer , cone-in-cone viscometer or cone-on-plate viscometer is used. 
Despite of all these it is still difficult to study the rheology of human blood. 
A small experiment where human blood was induced with ACD (anticoagulant citrate 
dextrose) solution a particular relationship between shear stress to shear strain rate was found 
which later developed as Casson's plot [11] as shown in figure 4 [8]. Casson's plot is also 
known as the double square root plot. It became apparent from these plots that blood behaves 
non-Newtonian near the origin implying that below 100 sec-1 shear strain rate it obeys the 
non-Newtonian regime and after certain rate above that it obeys Newtonian regime. The 
Casson's plot curves derives the following relationship between shear stress (Ƭ) and yield 
stress (Ƭy):   
0-20 sec-1:   Ƭ1/2 =  Ƭy1/2  +  ƞN1/2   γ̇1/2 
above 100sec-1: Ƭ1/2 =  ƞN1/2   γ̇1/2  or   Ƭ = ƞN γ̇    where ƞN is the ultimate 
Newtonian viscosity and γ̇ is the shear strain rate. Hence blood exhibits a viscoelastic 
behavior with the non-Newtonian property more dominating.  
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Figure 4: Non- Newtonian shear stress and shear strain rate along with Casson's Plot [8]      
2.3. Blood components: 
2.3.1. Blood plasma: 
Plasma is the suspension portion of the blood which contains the RBCs, 
WBCs and platelets along with other proteins and salts.  The normal range of blood plasma 
viscosity varies between 1.10 and 1.35 centipoise(cP) [6], [7]. The change in plasma 
viscosity directly affects the blood viscosity value. This change is irrelevant to the hematocrit 
value and the other cellular elements. Studies have shown that plasma acts as a Newtonian 
fluid but the presence of elements in it makes it to behave as non- Newtonian. 
2.3.2. RBC aggregation and deformation: 
The pattern of flow streamlines depend on the concentration of RBCs and the 
deformation of these cells under pressure, specifically shear forces. RBCs affects the flow of 
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blood in a vessel by either subjecting itself to sedimentation against gravity or the 
densification process thereby increasing the hematocrit value[9].  
Healthy RBCs easily responds to applied forces and gets deformed with 
changes in their shape. RBCs have biconcave disk shape which also behave as elastic bodies. 
Generally the deformation is reversible but in cases of increased shear rate, the change 
happens for permanently. Due to the shape change and applied pressure, the RBCs aggregate 
to form linear arrays in the form of stack of coins, termed as rouleaux. These further 
aggregate to form 3D structures. The aggregate formation increases the blood viscosity to a 
great extent.   
 
Figure 5: Relationship between the viscosity of blood and the shear rate [6] 
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Within normal blood parameters, the aggregation process is in balance with 
disaggregating forces.  An increase in the shear rate disintegrate the aggregates and a 
reduction the shear rate would increase the aggregate formation(9). Figure 5[6] gives an 
overview of the aggregation and deformation curve with applied shear rate.  
2.3.3. Hematocrit: 
Hematocrit is the value which gives the measure of red blood cells in the 
blood by percentage volume. It defines the packed RBC cell volume. This value varies 
differently for men and women from a range of 40.7 -50.3 %, 36.1-44.3%, respectively. 
Figure 6 [1] [6] shows the correlation between the viscosity and the hematocrit value of 
blood.  
 
Figure 6:  Graph showing relationship between blood viscosity and hematocrit value. [1] [6] 
It can be observed from figure 6 [1] [6] that there is an exponential increase in 
the value of viscosity with an increase in the hematocrit value. There is an increase of 4% in 
blood viscosity for a unit increase of hematocrit at medium to high shear rates. The relation 
between hematocrit  H and plasma viscosity ƞp can be given as  
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ƞN = ƞp { 1+ 0.025H + 7.35 * 10-4 H2} where ƞN is the ultimate Newtonian 
viscosity over a range of ƞN ranging from 0.03 P at hematocrit of 40 to 0.10 at hematocrit 65 
[8] . 
For non- Newtonian regime, the yield stress (Ƭy) is best correlated with 
hematocrit over a range to 30-50 with the following equation:  
Ƭy = A (H-Hc)3 where A is constant ranging between 0.6-1.2 * 10-6 and Hc is 
the limiting hematocrit between 4 and 8. The value of A is highly dependent on the 
fibrinogen concentration.  At a hematocrit of 40 the yield stress value is typically 0.04 
dyne/cm2. With an increase in the hematocrit value above 50, the blood displays various 
rheological abnormalities.  
2.3.4. Fibrinogen: 
As stated above the fibrinogen concentration plays a major role in the blood 
viscosity determination. The fluid pattern of blood heavily depends on the red blood cell and 
fibrinogen interaction. The variation of yield stress Ƭy and fibrinogen concentration Cf can be 
given by the equation  
Ƭy = B Cf2   
where B is a constant varying between 1 * 10-11 to 2 * 10-11 and weakly 
depends on the concentration of other proteins in the blood plasma. This equation is valid 
over a range of 100-400 mg% concentration of fibrinogen [8].  
2.3.5. Temperature:  
When blood follows the range of Newtonian fluid, it is observed that the 
temperature coefficient of viscosity is same as that of water over a range of 10-37 C [10]. In 
the non-Newtonian range , the viscosity and fluid flow are less affected by the temperature. 
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For 90% of human subjects the yield stress was independent of temperature but for the rest of 
1% there was a small increase in the yield stress with a decrease in the temperature.  
2.3.6. WBCs and Platelets: 
Generally WBCs and platelets does not contribute to the macroscopic fluid 
properties of blood due to the less concentration of these components as compared to the 
RBCs present. These although influence the blood flow resistance in microcirculation. 
2.3.7. Thrombosis:  
Thrombosis in general terms is the clotting of blood. Blood clotting in the 
pumps is a major factor of pump failure. Thrombosis happens as a result of red blood cell 
aggregation at high shear rates which induces the activation of platelets and fibrin forming 
first a mesh like structure leading to the clot formation. Thrombosis results in the increase in 
the blood viscosity which in some cases leads to clotting of remaining blood in contact. 
2.4. Effect of fluid mechanics on pump development: 
   While design the pump we have to keep in consideration the semi 
Newtonian and non-Newtonian fluid pattern of the blood along with all the above mentioned 
factors affecting the viscosity of blood. Since the pump acts on the arterial blood pressure, 
the flow velocity becomes sufficiently high indicating that the shear stress corresponds to the 
Newtonian part of the blood fluid dynamics. The viscosity of blood flowing through tubes 
having smaller diameter reduces and as the diameter decreases further, the viscosity value 
increases sharply. 
Also the hematocrit value of blood inside the tube is less and the hematocrit 
value at the discharge outlet i.e., at outflow is more. During the flow of blood through a 
vessel two major factors affect the blood viscosity thereby leading to clot formation: a) the 
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sedimentation of red blood cells due to effect of gravity to the vessel lining, b) when in 
vertical position due to axial movement of red blood cells in the vessel, flow resistance is 
reduced leading to low viscous regions near the tubes of the vessel wall. Hence blood flow 
velocity and pumping efficiency depends on the aggregation and deformability capacity of 
red blood cells, sedimentation property due to orientation of pump and gravity, tube 
diameter, fibrinogen to fibrin formation.  
Also lysed red blood cells, free hemoglobin in plasma and presence of air 
bubbles affects the pump function. Lysed red blood cells comes in contact with healthy cells 
and thereby activates fibrinogen forming aggregates of these lysed (ghost) cells. If the free 
hemoglobin concentration in the plasma increases then it results in the increase of yield 
stress. The chance of developing air bubbles in the pump can have a lethal impact on the 
person as it leads to hemolysis: the breaking of red blood cells releasing the hemoglobin into 
blood plasma which induces a reaction chain of thrombosis and embolization (formation and 
circulation of embolus, an intravascular mass) . Understanding these factors help in the 
development of a better pulsatile pump although in-depth apprehension of blood rheology 
still needs to be carried out. 
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CHAPTER 3 
DESIGN PRINCIPLE AND WORKING 
3.1. Design: 
As discussed in the previous chapters the major hurdle in the development of 
the pump is to design a model which can minimize the shear stress and therby can reduce the 
blood cell damage it causes. To achieve such a design different design prototypes were 
considered with extensive research and  one working design is proposed which considers the 
principle of a low shear pump and utilizes a unique geometry and pumping actuation 
mechanism.  
The proposed working prototype of the pump was created using AutoCAD. 
The following figures shows the front view and side views of the pump. 
 
Figure 7:  Front view of the proposed pump 
30 
 
 
 
  
 
Figure 8: Side views of the pump design. 
To validate the two dimensional design, we needed to study the volume 
covered inside the tube, flow obtained and which pattern of flow is observed. To understand 
the volume contained by our design mathematical calculations can be used.  The pump 
design can be approximated to the combination of two cylinders with an ellipsoid. Now the 
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total volume contained inside the pump will be the addition of volume of two cylinders and 
the volume of ellipsoid.  
Volume of pump= 2* volume of cylinder + volume of ellipsoid 
                             = 2 * π*(4.5)2(25)+ 4/3* π* 50/2*30.2/2*30.2/2 
                             = 2* 1590.43 + 23865.0467  mm3 
                             = 2 * 1.59 + 23.86 cm3 (approx) 
                             =  27.04 cm3 (approx) 
Now this implies 0.027 liters per sec . So the per minute output will be (1.59+23.86)cm3 * 60 
minute. this can be equated to : 
Volume flow out = 25.45cm3 *60/ minute 
                              = .02545*60 L/min 
                              = 1.527 L/min (approx) 
So this falls under the proposed domain of the output that the design produces. Also to 
validate the design technical aspects and to check whether the design produces a flow patter 
in the laminar flow range we calculated the Reynolds number at the output of the pump.  In 
general, Reynolds number = ρQD/ μA where ρ is the density of blood (1060 kg/m3), Q is the 
flow rate, D is the diameter of the tube, μ is the dynamic viscosity of blood (3.5*10-3 Pa.s) 
and A is the cross sectional area of the tube. 
Reynolds number= (1060*25.45*10-6*0.009)/ 3.5*10-3*π*0.009(4.5+25)*10-3 
                               = 83.2 (approx) , showing that the flow obtained at the end is a laminar 
flow. 
A three dimensional figure of the model was created which shows the pump 
as a whole with its input and output outlets. Figure 9 shows the 3D picture depicting the 
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sphincters and valves of the pump. Figure 10 and figure 11 shows the two dimensional cut 
section and the layer section of the pump.  
 
Figure 9 : Three dimensional model of the proposed pump 
 
Figure 10: The two dimensional cut section  
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Figure 11: Layer section of the pump 
After the two dimensional and three dimensional design manifestation, to aid 
this design the flow dynamics of the model is studied using COMSOL simulation. 
3.2. Principle: 
The design and working principle of the pump are developed by considering 
all the major factors affecting the current pumping and assistive systems. The main principle 
involved in the design of the pump is the implementation of the pulsatile motion into the 
pump which biomimics the actual heart compression and pulsation. The duty of the pump is 
to provide assistance to a weak pumping heart.  After studying the arterial pressure and 
cardiac output of the heart, the blood flow was stated according to the Darcy's Law of 
calculating Mean Arterial Pressure (MAP). According to this law : 
MAP= CO*SVR + CVP  
where CO is cardiac output, SVR is systemic vascular resistance, CVP is 
central venous pressure. This equation can be simplified as MAP ~ Pdias + 1/3 * (Psys - Pdias), 
where Pdias is diastolic pressure and Psys is the systolic pressure. For patients having low 
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pumping pressure and to increase the blood pressure, the pump would provide an increase of 
20% to blood pressure by pumping the blood from the venous supply to the arterial supply as 
seen from figure 12. For this purpose the blood pumping flow rate should reach the 20% of 
the normal rate, which make the proposed pump to produce a flow rate in between 1L/min to 
2L/min.  
As discussed in the earlier chapter the high speed rotation pumps and 
displacement pumps produces high shear stress which cause blood thrombosis and 
embolization. So the pump design has to be a prototype which causes low blood damage and 
to achieve this, pulsatile pumping motion mimicking the actual heart compression and 
decompression process is used. 
 
Figure 12:  Proposed positioning of the pump in development. 
The pump has a minimum pressure capacity of 120 mmHg  at 50 to 150 heart 
beats per minute. Since the pump design provides 50 to 120 beats/minute, the average 
number of times it beats per minute can be calculated as: 50+120/2=85 beats (average)/min. 
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Therefore, time taken for one beat will be: 60/85= 0.7058 sec approximately. Process of 
compression and decompression relates to one complete cycle of pump. So compression and 
decompression takes half of the pump cycle respectively. Therefore time taken to compress 
could be approximated as 0.7058/2= 0.3529 sec. Similarly the time taken to decompress also 
approximates to 0.3529 sec. This pressure can be measured using blood pressure sensors or 
direct electro cardiac sensing. This pumping principle provides a wide variety of applications 
not just limited to the arterial pumping. 
3.3 Working Mechanism: 
As described in the principle, the proposed pump works on the pulsatile 
compression an d decompression mechanism of the heart. The design follows unique 
geometry where we first study the flow and fluid dynamics using simulation techniques. The 
proposed theory of pump can use shape memory alloy actuators which helps in the 
compression of the pumping chamber. Also pneumatic cuffs can be used to inflate and 
deflate the pump body. These cuffs also control the compression of the sphincters attached at 
the input and the output which are used to minimize the thrombosis caused by turbulence. 
Although shape memory actuators can also be used, the design with pneumatic cuffs has 
been studied as it helps simple sequencing of the two-way valve.  
Figure 13 shows the prototype model using the pneumatic cuffs for the 
compression and decompression of the pump. The pump follows a basic mechanism: as the 
blood flows in through the input, the input valve opens creating the pump chamber to inflate 
and then as soon the chamber fills in, pressure builds up causing the input valve to close and 
the output valve opens which thereby results in the compression of the pump and output flow 
of blood. To achieve sequential actuation of complex and continuous flow pattern in the 
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pump, a cluster of pumps (each independently controlled) can be packaged together with low 
turbulence flow. This type of zonal compression allows optimal compression for blood flow. 
 
 
Figure 13 :  A  pneumatic version of the pumping apprentice. (1) outgoing sphincter valve 
controlled by pneumatic cuff, outer titanium case, (3) main pump pneumatic cuff actuator, 
(4) polymer pump body with PEO lining, (5) inlet sphincter valve cuff, (6) 6-axis 
accelerometer chips for actuation analysis, (7) pneumatic control lines, (8) valve to control 
actuation, (9) pneumatic pump (saline or gas). 
3.4. Simulation: 
As described earlier, to fully understand the mechanism of fluid flow of the 
proposed pump design and to aid the design development, the simulation study of the pump 
is conducted through COMSOL multiphysics software. To better understand the fluid flow 
properties a peristaltic model is stimulated which can help understand the stress applied on 
the fluid and to observe the velocity field of the flow in the pump. 
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In the developed model, the flow of fluid is through a cylindrical pipe and 
external pressure is applied which leads to the deformation of the tube thereby creating stress 
in the fluid. The simulation consist of transient analysis based on incompressible Navier-
Stokes equation which is given by  
   
where  is density (kg/m3),  is flow velocity (m/s), ƞ is viscosity (Pa.s) and 
p is pressure. The model uses simple geometric construction of a rectangle to model a 
cylinder as seen from figure 14 and has a set of constants tabulated in table 2. 
Figure 14:  Geometric model construction  
The model use three application modes: axial symmetry, stress-strain ; 
moving mesh and incompressible Navier- Stokes system. Hence this model becomes a 
combination of structural mechanics and fluid dynamics. The moving mesh application is 
used to study the deforming geometry of the model.  
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Table 7:  Set of Constants used for modeling  
For developing the fluid simulation, the boundary conditions at the inlet and 
outlet of the pump assumes that : 
    
This implies that the total stress at the inlet and the outlet of the pump is zero. 
While configuring the moving mesh, it is fixed to a zero r displacement at the symmetry axis 
and at the top and bottom of the tube it is at a zero z displacement. To obtain the volumetric 
flow rate ( V̇ ) in m3/s at the input and output is given by  
   
where n is the outward-pointing unit normal and s is the boundary length 
parameter. Similarly the total volume of the fluid in m3 can be calculated using  
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where A is the deformed domain. Vpump is the volume of fluid that comes out 
through the outlet. The derivative equation is then used to derive the above stated integral. 
The boundary conditions for the model are set accordingly and a major equation is used to set 
the edge load i.e. the load or the decompression on the pump. The load acting is force per 
unit area with a boundary setting of {-Lmax*flc2hs((t-t_on)[1/s], dt[1/s])*gauss((z-
0.05)[1/m],width[1/m])*flc2hs((t_off-t)[1/s],dt[1/s])} where the middle factor plays a major 
role in the positioning of the pressure. In the simulation we apply the load at the midpoint of 
the tube.  
 
Figure 15:  End result of simulation depicting the load applied 
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Figure 15 shows the end result of the simulation with the velocity -
deformation profile. A full detailed report of the simulation with all the tables and boundary 
conditions are provided in Appendix 2. 
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CHAPTER 4 
MATERIAL USED 
 
The material used to develop the inner sheathing of the pump is implant grade 
liquid silicone rubber (LSR). Liquid silicone rubber is a curated silicone with high purity 
platinum at low compression set properties which has more stability towards extreme 
temperature variation from hot to cold and can also be molded into various wall thickness 
within a same part - a requirement for the production of high quality parts.  
4.1. Chemical background and uses: 
Liquid silicone rubber belongs to a family of thermoset elastomers with a 
chemical backbone of alternating silicon and oxygen atoms with methyl or vinyl side groups. 
The methyl group in the side chains contribute to the hydrophobicity of the material. The 
LSR used in the project has dimethyl chains. LSR has been specially used by the medical 
device manufacturers to produce more stable, flexible and physically implantable quality 
products. Some of the application of silicone rubber is in the manufacturing of precision 
molded parts, diaphragms, septa, valves, plungers etc. Since platinum cured, the rubber has 
long shelf life with excellent chemical resistance. 
4.2. Basic properties: 
LSR used in the molding procedure was manufactured by Applied Silicone 
Corporation. The LSR came in two parts A and B, both being colorless, translucent and 
ultraviolet- and strain resistant. The material has the property to withstand high strength 
which is basic requirement for the pump development.  To obtain the elastomer of desired 
toughness and rubbery texture both the parts A and B (figure 16) are to mixed in equal 
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proportion [12].  Despite of its virtual unlimited shelf life, the manufacturer suggest a shelf 
life upto 3 years for molded parts. The specific material used for the project from Applied 
Silicone Corporation has long term implantation capacity with high durability.  
 
Figure 16: Packed Liquid silicone rubber as Part A and Part B.  
One of the eye catching property of LSR is its biocompatibility. It is also 
hypoallergenic which implies that the implanted device or part will have minimum risk of 
developing an allergic reaction in the host body. It also has anti-bacterial and fungal 
properties resulting in minimal chances of developing any bacterial or fungal infections in 
the body. LSR belongs to a family of thermosets resulting in its property of withstanding 
wide range of temperature change ( -55oC to 200oC) allowing it to go through sterilization 
processes like autoclaving without changing its properties.  
4.3. LSR usage in laboratory:  
When mixed part A and part B in a 1:1 ratio under proper conditions and with 
required specific inner dimensions of the pump, two molds were made.  
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Figure 17 shows the molds made in the laboratory to study the device inner 
dynamics. 
 
Figure 17: The two inner surface moulds made out of LSR 
Further specific details of the properties of LSR from applied silicone 
corporation can be referred by the material safety data sheet (MSDS) of LSR systems from 
Appendix 1. 
 
 
 
 
 
44 
 
 
 
CHAPTER 5 
DISCUSSION AND CONCLUSION 
 
A potential working prototype of a heart mimicking pump have been 
proposed. To overcome the disadvantages of  the current pumps available in the market, 
different actuation methods and blood fluid dynamics have been studied. A vast majority of 
heart assist devices are complete bypass or large volume pumps that can cause significant 
blood cell damage which results in the thrombosis and thereby causes blood clotting and 
increases stroke/ heart failure chances. 
The proposed design of the pump works on the basis of  mimicking the actual 
heart pumping mechanism: the pulsatile compression and decompression. This mechanism 
helps in achieving the required flow rate with a less turbulent blood flow resulting in minimal 
blood cell damage. The pump under development focuses a lot on the prevention of damage 
to the blood cells due to the turbulent flow of blood in other rotary and displacement pumps.  
The pumping action of the device is created by the pressure gradient against the continuous 
flow. In general, continuous flow pumps produces non-pulsatile flow using a rotor which 
generally contains magnets that leads to a turbulence in the blood. 
The use of COMSOL simulation has aided to the better understanding of the 
design and the blood flow dynamics. The studies through COMSOL simulation has 
suggested that the proposed design provides a lesser shear rate as compared to other heart 
assist devices which added as an advantage. The design also includes sphincter-like valves 
that also helps minimize the thrombosis which in other pumps is a result of turbulence. The 
design takes special care into the biocompatibility of the material used and in order to 
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achieve this, it is can be coated with a layer of polyethylene oxide (PEO) which reduces the 
protein interaction on the pump interior surfaces.  
The actual compression and decompression of the pump caused by the 
sphincter valves are controlled by pneumatic cuffs. To improve the design capacities both 
shape memory alloys and pneumatic cuffs implementation has been studied. The pneumatic 
cuffs around the pump can help in the inflation and the deflation of the sphincter valves. This 
results in a zonal compression of the pump which give an optimized blood flow rate. Further 
research has been carried out with the prototype having pneumatic cuffs rather than shape 
memory alloys as it provides simple sequencing on the two way valves. Accelerometers are 
incorporated to the design that analyses the pump body motion and can provide a feedback of 
the pumping action. Further a cluster of pumps can be packed together to obtain complex 
flow patterns. 
This blood pump design can provide upto 20% of cardiac assist to persons 
suffering from congestive heart failure and other heart abnormalities where extra blood 
pumping assistance is required. The pump also has minimum pressure capacity of 120mmHg 
at 50-150 heart beats per minute. Also the design suggested and in development have a broad 
spectrum of uses. This design is not just limited to the arterial to arterial pumping but can be 
used for physiological fluidic maintenance, intravenous drug delivery and pressure 
maintenance and to other applications where a low turbulence and shear stress is required.   
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APPENDIX 1 
MATERIAL SAFETY DATA SHEET  
LIQUID SILICONE RUBBER (LSR) SYSTEMS 
 
I. PRODUCT IDENTIFICATION 
 A. Manufactured by: 
  APPLIED SILICONE CORPORATION For Chemical Emergency 
  270 QUAIL COURT Please call CHEMTREC 
  SANTA PAULA, CA 93060 (800) 424-9300 
  Telephone:  (805) 525-5657 
  Fax: (805) 933-1675 
 B. Trade Name:  Liquid Silicone Rubber (LSR), Part A and Part B 
 C. Chemical Name and Synonyms:  Part A: reinforced dimethyl methylvinyl 
siloxanes. Part B: reinforced dimethyl methylhydrogen siloxanes. 
 D. Chemical Formula:  N/A (polymeric), both Part A and Part B. 
 E. Chemical Family:  Part A: reinforced organopolysiloxane, Part B: 
organopolysiloxane 
 F. DOT (CFR 49) Hazard Classification: Not hazardous per CFR 49 
 
II. PRODUCT COMPOSITION 
  Dimethyl Silicone Elastomer Base, 100% 
 
III. PHYSICAL PROPERTIES – PART A 
 A. Boiling Point:  >260 oC 
 B. Specific Gravity (water = 1):  1.1 
 C. Vapor Pressure at 25 oC:  >1 mm Hg - essentially non-volatile 
 D. Vapor Density (Air = 1):  N/A - essentially non-volatile 
 E. Water Solubility:  nil 
 F. Evaporation Rate (Ethyl Ether = 1):  nil 
 G. Appearance and Odor:  Colorless, translucent, viscous, paste 
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III. PHYSICAL PROPERTIES - PART B 
 A. Boiling Point:  >260oC 
 B. Specific Gravity (water = 1):  1.1 
 C. Vapor Pressure at 25oC:  negligible - essentially non-volatile 
 D. Vapor Density (Air = 1):  N/A - essentially non-volatile 
 E. Water Solubility:  nil 
 F. Evaporation Rate (Ethyl Ether = 1):  N/A 
 G. Appearance and Odor:  Colorless, translucent, viscous, paste. 
 
IV. FIRE AND EXPLOSION INFORMATION – PART A AND PART B 
 A. Flash Point (Open Cup):  Part A: 190oC; Part B: 95oC 
 B. Flammable Limits in Air, % Volume:  Not measured 
 C. Extinguishing Media:  Use water fog, dry chemical, foam, or CO2 
 D. Special Fire Fighting Procedures:  Fire fighters should wear self-contained 
breathing apparatus and full protective clothing.  Use water spray to cool nearby 
containers. 
 E. Unusual Fire and Explosion Hazards:  Part B may generate Hydrogen gas to create 
an explosion hazard. 
 
V. HEALTH HAZARD AND PROTECTION DATA - PART A AND PART B 
 A. Personal Protection Recommended:  Wear protective goggles to prevent eye 
contact.  Under recommended conditions of use, no other protection should be 
required. 
 B. Signs and Symptoms of Exposure:  The primary route of exposure is eye contact. 
Direct eye contact can cause a transitory irritation, but it is not injurious.  This 
irritation may persist for up to 24 hours. 
  Experience with this material has not indicated any serious effects related to 
exposure by any route.   
 C. First Aid for Exposure: 
  1. Eye contact:  Flush with water.  Get medical attention if irritation persists. 
  2. Skin contact:  Not considered a potential hazard. If irritation occurs, wash 
thoroughly with soap and water. 
  3. Ingestion:  Get medical attention 
  4. Inhalation: Not considered a potential hazard.  
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D.  Occupational Exposure Limits:  Because of the low health hazard, no exposure 
limits have been established. 
E.  Eye irritant in raw state.  
F.   Medical Conditions Generally Aggravated by Exposure:  Pre-existing eye 
disorders. 
G.  Toxicity:  Because of the low toxicity, specific toxicity data is unavailable. 
 
VI. SPILL AND LEAK PROCEDURES - PART A AND PART B 
 Use personal protection recommended in section V to prevent personnel exposure. 
 Even small amounts of spilled material may present a slip hazard.  
 As required, dike with soil or other absorbent materials to prevent spread of spill.  Mop 
or wipe up and place in appropriate containers and/or place absorbent material on spill 
and transfer absorbed solvent to appropriate containers. Clean any remaining slippery 
surfaces. Mop or swab with appropriate solvent or wash with mild caustic detergents.  
 
VII. REACTIVITY DATA - PART A AND PART B 
 A. Stability:  This material is chemically stable.  Hazardous polymerization will not 
occur. 
 B. Materials to Avoid:  Strong alkali contact with Part B may generate flammable 
hydrogen gas. 
 C. Hazardous Decomposition Products:  Burning may liberate carbon monoxide, 
carbon dioxide and silicone dioxide. 
 
VIII. OTHER INFORMATION AND PRECAUTIONS - PART A AND PART B 
 Store in a cool, dry place. Keep container closed and keep away from heat and flame. 
Do not lay container on its side. 
          To the best of our knowledge this material does not contain any substances listed by 
the state of California to cause cancer, birth defects, or other reproductive effects.   
          When this material is discarded, as received, it is not classified as a RCRA hazardous 
waste. state and local laws may impose additional regulatory requirements regarding 
disposal.  
          Consult and comply with federal, state, and local regulations concerning any release of 
hazardous materials into the water, water piping systems, ground, or air.  Consult and 
comply with federal, state, and local regulations concerning removal of waste. 
All information appearing herein is based upon data considered to be accurate.  However, no 
warranty is expressed or implied regarding the accuracy of these data or the results to be 
obtained from the use thereof. 
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APPENDIX 2 
COMSOL SIMULATION RESULT 
1. Model Properties 
Property Value 
Model name Peristaltic Pump 
Author COMSOL 
Company COMSOL 
Department   
Reference Copyright (c) 1998-2008 by COMSOL AB 
URL www.comsol.com 
Saved date Apr 10, 2015 2:16:34 PM 
Creation date Nov 17, 2008 7:12:05 PM 
COMSOL version COMSOL 3.5.0.603 
Application modes and modules used in this model: 
• Geom1 (Axial symmetry (2D)) 
o Axial Symmetry, Stress-Strain 
o Moving Mesh (ALE) 
o Non-Newtonian Flow (Chemical Engineering Module) 
1.1. Model description 
Peristaltic Pump 
Rollers are squeezing a flexible tube in this model of a peristaltic pump. The compression 
drives a fluid through the tube. The motion of the fluid is computed with the help of a 
Moving Mesh application mode. 
 
2. Constants 
 
Name Expression Value Description 
t_on 0.3[s]   Time when roll is engaged 
t_off 1.2[s]   Time when roll is disengaged 
dt 0.2[s]   Time to reach full force 
z0 0.03[m]   z coordinate where roll starts 
v0 0.03[m/s]   Vertical velocity of roll 
width 0.01[m]   Width of Gaussian force distribution 
Ttot 1.5[s]   Total time for a pump cycle 
Lmax 4e6[N/m^2]   Max load 
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3. Geometry 
Number of geometries: 1 
 
3.1. Geom1 
 
 
 
3.1.1. Point mode 
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3.1.2. Boundary mode 
 
 
 
3.1.3. Subdomain mode 
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4. Geom1 
Space dimensions: Axial symmetry (2D) 
Independent variables: R, PHI, Z 
 
4.1. Mesh 
4.1.1. Mesh Statistics 
 
Number of degrees of freedom 7741 
Number of mesh points 517 
Number of elements 916 
Triangular 916 
Quadrilateral 0 
Number of boundary elements 166 
Number of vertex elements 6 
Minimum element quality 0.924 
Element area ratio 0.398 
 
 
 
4.2. Application Mode: Axial Symmetry, Stress-Strain (axi) 
Application mode type: Axial Symmetry, Stress-Strain 
Application mode name: axi 
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4.2.1. Application Mode Properties 
 
Property Value 
Default element type Lagrange - Quadratic 
Analysis type Transient 
Specify eigenvalues using Eigenfrequency 
Frame Frame (ref) 
Weak constraints Off 
Constraint type Ideal 
 
 
4.2.2. Variables 
Dependent variables: uor, w 
Shape functions: shlag(2,'uor'), shlag(2,'w') 
Interior boundaries not active 
 
4.2.3. Boundary Settings 
 
Boundary   4 5-
6 
7 
Edge load 
(force/area) R-
dir. (Fr) 
N/m2 0 0 -0.5*Lmax*flc2hs((t-t_on)[1/s],dt[1/s])*gauss((z-
0.05)[1/m],width[1/m])*flc2hs((t_off-t)[1/s],dt[1/s]) 
Hr 1 0 1 0 
Hz 1 0 1 0 
 
4.2.4. Subdomain Settings 
 
Subdomain   2 
Young's modulus (E) Pa 2e9[Pa] (Nylon) 
Density (rho) kg/m3 1150[kg/m^3] (Nylon) 
 
4.3. Application Mode: Moving Mesh (ALE) (ale) 
Application mode type: Moving Mesh (ALE) 
Application mode name: ale 
 
4.3.1. Application Mode Properties 
 
Property Value 
Default element type Lagrange - Quadratic 
Smoothing method Winslow 
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Analysis type Transient 
Allow remeshing Off 
Defines frame Frame (ale) 
Original reference frame Frame (ale) 
Motion relative to Frame (ref) 
Weak constraints On 
Constraint type Non-ideal 
 
4.3.2. Variables 
Dependent variables: 
Shape functions: shlag(2,'lm3'), shlag(2,'lm4'), shlag(2,'r'), shlag(2,'z') 
Interior boundaries not active 
 
4.3.3. Boundary Settings 
 
Boundary   1 2-3 4 
Type   Mesh 
displacement 
Mesh 
displacement 
Mesh 
displacement 
Mesh displacement 
(deform) 
m {0;0} {0;0} {uaxi_axi;w} 
defflag   {1;0} {0;1} {1;1} 
 
4.3.4. Subdomain Settings 
 
Subdomain   1 2 
Shape functions 
(shape) 
  shlag(2,'lm3') shlag(2,'lm4') 
shlag(2,'r') shlag(2,'z') 
shlag(2,'lm3') shlag(2,'lm4') 
shlag(2,'r') shlag(2,'z') 
Integration order 
(gporder) 
  4 4 4 4 
type   Free displacement Prescribed displacement 
Displacement 
expressions (presexpr) 
m {0;0} {uaxi_axi;w} 
Subdomain initial value   1 2 
Spatial coordinate (r) m rinit_ale rinit_ale 
Spatial coordinate (z) m zinit_ale zinit_ale 
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4.4. Application Mode: Non-Newtonian Flow (chns) 
Application mode type: Non-Newtonian Flow (Chemical Engineering Module) 
Application mode name: chns 
 
4.4.1. Scalar Variables 
 
Name Variable Value Unit Description 
visc_vel_fact visc_vel_fact_chns 10 1 Viscous velocity factor 
 
4.4.2. Application Mode Properties 
 
Property Value 
Default element type Lagrange - P2 P1 
Analysis type Transient 
Corner smoothing Off 
Weakly compressible flow Off 
Turbulence model None 
Realizability Off 
Non-Newtonian flow On 
Brinkman on by default Off 
Two-phase flow Single-phase flow 
Swirl velocity Off 
Frame Frame (ale) 
Weak constraints On 
Constraint type Ideal 
 
4.4.3. Variables 
Dependent variables: u, v, w2, p, logk2, logd2, logw2, phi2, psi2, nrw2, nzw2 
Shape functions: shlag(2,'lm5'), shlag(2,'lm6'), shlag(1,'lm8'), shlag(2,'u'), shlag(2,'v'), 
shlag(1,'p') 
Interior boundaries not active 
 
4.4.4. Boundary Settings 
 
Boundary   1 2-3 4 
Type   Symmetry boundary Open boundary Inlet 
velType   U0in U0in u0 
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r-velocity (u0) m/s 0 0 uaxi_t_axi 
z-velocity (v0) m/s 0 0 wt 
 
4.4.5. Subdomain Settings 
 
Subdomain   1 
Shape functions 
(shape) 
  shlag(2,'lm5') shlag(2,'lm6') shlag(1,'lm8') shlag(2,'u') 
shlag(2,'v') shlag(1,'p') 
Integration order 
(gporder) 
  4 4 2 
Constraint order 
(cporder) 
  2 2 1 
Model parameter (m)   0.0161 
Model parameter (n) 1 .63 
idon   1 
cdon   0 
 
5. Materials/Coefficients Library 
5.1. Nylon 
 
Parameter Value 
Heat capacity at constant pressure (C) 1700[J/(kg*K)] 
Young's modulus (E) 2e9[Pa] 
Thermal expansion coeff. (alpha) 280e-6[1/K] 
Relative permittivity (epsilonr) 4 
Thermal conductivity (k) 0.26[W/(m*K)] 
Density (rho) 1150[kg/m^3] 
 
6. Global Equations 
 
Name (u) Equation Init (u) Init (ut) Description 
netflow netflowt-(inflow+outflow)/(2*Ttot) 0 0   
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7. Integration Coupling Variables 
 
7.1. Geom1 
7.1.1. Source Boundary: 2 
 
Name Value 
Variable name inflow 
Expression 2*pi*r*v 
Order 4 
Global Yes 
 
7.1.2. Source Boundary: 3 
 
Name Value 
Variable name outflow 
Expression 2*pi*r*v 
Order 4 
Global Yes 
 
7.1.3. Source Subdomain: 1 
 
Name Value 
Variable name Vol 
Expression 2*pi*r 
Order 4 
Global Yes 
 
8. Functions 
 
Function Expression Derivatives Complex 
output 
gauss(x,sigma) 1/(sigma*sqrt(2*pi))*exp(-
x^2/(2*sigma^2)) 
d(1/(sigma*sqrt(2*pi))*exp(-
x^2/(2*sigma^2)),x), 
d(1/(sigma*sqrt(2*pi))*exp(-
x^2/(2*sigma^2)),sigma) 
false 
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9. Solver Settings 
Solve using a script: off 
 
Analysis type Transient 
Auto select solver On 
Solver Time dependent 
Solution form Automatic 
Symmetric Auto 
Adaptive mesh refinement Off 
Optimization/Sensitivity Off 
Plot while solving Off 
 
9.1. Direct (PARDISO) 
Solver type: Linear system solver 
Parameter Value 
Preordering algorithm Nested dissection 
Row preordering On 
Bunch-Kaufmann Off 
Pivoting perturbation 1.0E-8 
Relative tolerance 1.0E-6 
Factor in error estimate 400.0 
Check tolerances Off 
 
9.2. Time Stepping 
 
Parameter Value 
Times range(0,0.01,1.5) 
Relative tolerance 0.01 
Absolute tolerance 1e-3 
Times to store in output Specified times 
Time steps taken by solver Strict 
Maximum BDF order 2 
Singular mass matrix Maybe 
Consistent initialization of DAE systems Backward Euler 
Error estimation strategy Exclude algebraic 
Allow complex numbers Off 
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9.3. Advanced 
 
Parameter Value 
Constraint handling method Elimination 
Null-space function Automatic 
Automatic assembly block size On 
Assembly block size 1000 
Use Hermitian transpose of constraint matrix and in symmetry detection Off 
Use complex functions with real input Off 
Stop if error due to undefined operation On 
Store solution on file Off 
Type of scaling Automatic 
Manual scaling   
Row equilibration On 
Manual control of reassembly Off 
Load constant On 
Constraint constant On 
Mass constant On 
Damping (mass) constant On 
Jacobian constant On 
Constraint Jacobian constant On 
 
10. Postprocessing 
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11. Variables 
 
11.1. Point 
11.1.1. Point 1-2 
 
Name Description Unit Expression 
RFR_axi Reaction force R-dir. N   
RFZ_axi Reaction force Z-dir. N   
FRg_axi Point load in global R dir. N   
FZg_axi Point load in global Z dir. N   
disp_axi Total displacement M   
uaxi_axi R-displacement m   
uaxiR_axi R derivative of R-displacement 1   
uaxiZ_axi Z derivative of R displacement 1   
uaxi_t_axi R-velocity m/s   
uaxi_tt_axi R-acceleration m/s^2   
rinit_ale r coordinate initial value m R 
zinit_ale z coordinate initial value m Z 
 
11.1.2. Point 3-6 
 
Name Description Unit Expression 
RFR_axi Reaction force R-dir. N if(R>0,2 * reacf(uor) * pi/R,0) 
RFZ_axi Reaction force Z-dir. N 2 * reacf(w) * pi 
FRg_axi Point load in global R dir. N 0 
FZg_axi Point load in global Z dir. N 0 
disp_axi Total displacement m sqrt(real(uaxi_axi)^2+real(w)^2) 
uaxi_axi R-displacement m uor * R 
uaxiR_axi R derivative of R-displacement 1 uorR * R+uor 
uaxiZ_axi Z derivative of R displacement 1 uorZ * R 
uaxi_t_axi R-velocity m/s uort * R 
uaxi_tt_axi R-acceleration m/s^2 uortt * R 
rinit_ale r coordinate initial value m R 
zinit_ale z coordinate initial value m Z 
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11.2. Boundary 
 
11.2.1. Boundary 1-3 
 
Name Description Unit Expression 
RFR_axi Reaction force R-dir. N   
RFZ_axi Reaction force Z-dir. N   
FRg_axi Edge load in global R-
dir. 
N/m^2   
FZg_axi Edge load in global Z-
dir. 
N/m^2   
disp_axi Total displacement m   
uaxi_axi R-displacement m   
uaxiR_axi R derivative of R-
displacement 
1   
uaxiZ_axi Z derivative of R 
displacement 
1   
uaxi_t_axi R-velocity m/s   
uaxi_tt_axi R-acceleration m/s^2   
TaR_axi Surface traction 
(force/area) in R dir. 
Pa   
TaZ_axi Surface traction 
(force/area) in Z dir. 
Pa   
rinit_ale r coordinate initial value m R 
zinit_ale z coordinate initial value m Z 
K_r_chns Viscous force per area, r 
component 
Pa eta_chns * (2 * nr_chns * ur+nz_chns * 
(uz+vr)) 
T_r_chns Total force per area, r 
component 
Pa -nr_chns * p+2 * nr_chns * eta_chns * 
ur+nz_chns * eta_chns * (uz+vr) 
K_z_chns Viscous force per area, z 
component 
Pa eta_chns * (nr_chns * (vr+uz)+2 * 
nz_chns * vz) 
T_z_chns Total force per area, z 
component 
Pa -nz_chns * p+nr_chns * eta_chns * 
(vr+uz)+2 * nz_chns * eta_chns * vz 
 
11.2.2. Boundary 4 
 
Name Description Unit Expression 
RFR_axi Reaction force R-dir. N if(R>0,2 * reacf(uor) * pi/R,0) 
RFZ_axi Reaction force Z-dir. N 2 * reacf(w) * pi 
FRg_axi Edge load in global N/m^2 0 
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R-dir. 
FZg_axi Edge load in global 
Z-dir. 
N/m^2 0 
disp_axi Total displacement M sqrt(real(uaxi_axi)^2+real(w)^2) 
uaxi_axi R-displacement M uor * R 
uaxiR_axi R derivative of R-
displacement 
1 uorR * R+uor 
uaxiZ_axi Z derivative of R 
displacement 
1 uorZ * R 
uaxi_t_axi R-velocity m/s uort * R 
uaxi_tt_axi R-acceleration m/s^2 uortt * R 
TaR_axi Surface traction 
(force/area) in R dir. 
Pa sR_axi * nR_axi+sRZ_axi * nZ_axi 
TaZ_axi Surface traction 
(force/area) in Z dir. 
Pa sRZ_axi * nR_axi+sZ_axi * nZ_axi 
rinit_ale r coordinate initial 
value 
M R 
zinit_ale z coordinate initial 
value 
M Z 
K_r_chns Viscous force per 
area, r component 
Pa eta_chns * (2 * nr_chns * ur+nz_chns * 
(uz+vr)) 
T_r_chns Total force per area, 
r component 
Pa -nr_chns * p+2 * nr_chns * eta_chns * 
ur+nz_chns * eta_chns * (uz+vr) 
K_z_chns Viscous force per 
area, z component 
Pa eta_chns * (nr_chns * (vr+uz)+2 * nz_chns * 
vz) 
T_z_chns Total force per area, 
z component 
Pa -nz_chns * p+nr_chns * eta_chns * (vr+uz)+2 
* nz_chns * eta_chns * vz 
 
11.2.3. Boundary 5-6 
 
Name Description Unit Expression 
RFR_axi Reaction force R-dir. N if(R>0,2 * reacf(uor) * pi/R,0) 
RFZ_axi Reaction force Z-dir. N 2 * reacf(w) * pi 
FRg_axi Edge load in global R-dir. N/m^2 0 
FZg_axi Edge load in global Z-dir. N/m^2 0 
disp_axi Total displacement m sqrt(real(uaxi_axi)^2+real(w)^2) 
uaxi_axi R-displacement m uor * R 
uaxiR_axi R derivative of R-displacement 1 uorR * R+uor 
uaxiZ_axi Z derivative of R displacement 1 uorZ * R 
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uaxi_t_axi R-velocity m/s uort * R 
uaxi_tt_axi R-acceleration m/s^2 uortt * R 
TaR_axi Surface traction (force/area) in 
R dir. 
Pa sR_axi * nR_axi+sRZ_axi * 
nZ_axi 
TaZ_axi Surface traction (force/area) in 
Z dir. 
Pa sRZ_axi * nR_axi+sZ_axi * 
nZ_axi 
rinit_ale r coordinate initial value m R 
zinit_ale z coordinate initial value m Z 
K_r_chns Viscous force per area, r 
component 
Pa   
T_r_chns Total force per area, r 
component 
Pa   
K_z_chns Viscous force per area, z 
component 
Pa   
T_z_chns Total force per area, z 
component 
Pa   
 
11.2.4. Boundary 7 
 
Name Description Unit Expression 
RFR_axi Reaction force R-dir. N if(R>0,2 * reacf(uor) * pi/R,0) 
RFZ_axi Reaction force Z-dir. N 2 * reacf(w) * pi 
FRg_axi Edge load in global R-dir. N/m^2 FR_axi 
FZg_axi Edge load in global Z-dir. N/m^2 0 
disp_axi Total displacement m sqrt(real(uaxi_axi)^2+real(w)^2) 
uaxi_axi R-displacement m uor * R 
uaxiR_axi R derivative of R-displacement 1 uorR * R+uor 
uaxiZ_axi Z derivative of R displacement 1 uorZ * R 
uaxi_t_axi R-velocity m/s uort * R 
uaxi_tt_axi R-acceleration m/s^2 uortt * R 
TaR_axi Surface traction (force/area) in 
R dir. 
Pa sR_axi * nR_axi+sRZ_axi * 
nZ_axi 
TaZ_axi Surface traction (force/area) in 
Z dir. 
Pa sRZ_axi * nR_axi+sZ_axi * 
nZ_axi 
rinit_ale r coordinate initial value m R 
zinit_ale z coordinate initial value m Z 
K_r_chns Viscous force per area, r 
component 
Pa   
T_r_chns Total force per area, r Pa   
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component 
K_z_chns Viscous force per area, z 
component 
Pa   
T_z_chns Total force per area, z 
component 
Pa   
 
11.3. Subdomain 
 
11.3.1. Subdomain 1 
 
Name Description Unit Expression 
RFR_axi Reaction force R-
dir. 
N   
RFZ_axi Reaction force Z-
dir. 
N   
FRg_axi Body load in global 
R-dir. 
N/m^3   
FZg_axi Body load in global 
Z-dir. 
N/m^3   
disp_axi Total displacement M   
uaxi_axi R-displacement M   
uaxiR_axi R derivative of R-
displacement 
1   
uaxiZ_axi Z derivative of R 
displacement 
1   
uaxi_t_axi R-velocity m/s   
uaxi_tt_axi R-acceleration m/s^2   
sR_axi sR normal stress 
global sys. 
Pa   
sZ_axi sZ normal stress 
global sys. 
Pa   
sPHI_axi sPHI normal stress Pa   
sRZ_axi sRZ shear stress 
global sys. 
Pa   
eR_axi eR normal strain 
global sys. 
1   
eZ_axi eZ normal strain 
global sys. 
1   
ePHI_axi ePHI normal strain 1   
eRZ_axi eRZ shear strain 1   
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global sys. 
sr_t_axi Time der. of normal 
stress global sys. 
(sR) 
Pa/s   
sz_t_axi Time der. of normal 
stress global sys. 
(sZ) 
Pa/s   
sphi_t_axi Time der. of normal 
stress (sPHI) 
Pa/s   
srz_t_axi Time der. of shear 
stress global sys. 
(sRZ) 
Pa/s   
er_t_axi eR_t normal 
velocity strain 
global sys. 
1/s   
ez_t_axi eZ_t normal 
velocity strain 
global sys. 
1/s   
ephi_t_axi ePHI_t normal 
velocity strain 
1/s   
erz_t_axi eRPHI_t shear 
velocity strain 
global sys. 
1/s   
mises_axi von Mises stress Pa   
Ws_axi Strain energy 
density 
J/m^3   
evol_axi Volumetric strain 1   
tresca_axi Tresca stress Pa   
rinit_ale r coordinate initial 
value 
m R 
zinit_ale z coordinate initial 
value 
m Z 
dr_ale r-displacement m r-R 
dz_ale z-displacement m z-Z 
U_chns Velocity field m/s sqrt(u^2+v^2) 
V_chns Vorticity 1/s uz-vr 
divU_chns Divergence of 
velocity field 
1/s ur+vz+u/r 
sr_chns Shear rate 1/s sqrt(0.5 * (4 * ur^2+2 * (uz+vr)^2+4 * 
vz^2+4 * u^2/(r+eps)^2)+eps) 
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cellRe_chns Cell Reynolds 
number 
1 rho_chns * U_chns * h_ale/eta_chns 
res_u_chns Equation residual 
for u 
Pa r * (rho_chns * (ut+u * ur+v * uz)+pr-
F_r_chns)+2 * eta_chns * (u/r-ur)-
eta_chns * r * (2 * urr+uzz+vrz) 
res_v_chns Equation residual 
for v 
Pa r * (rho_chns * (vt+u * vr+v * vz)+pz-
F_z_chns)-eta_chns * (r * (vrr+uzr)+2 * r 
* vzz+uz+vr) 
beta_r_chns Convective field, r 
component 
Pa*s r * rho_chns * u 
beta_z_chns Convective field, z 
component 
Pa*s r * rho_chns * v 
Dm_chns Mean diffusion 
coefficient 
kg/s r * eta_chns 
da_chns Total time scale 
factor 
kg/m^2 r * rho_chns 
taum_chns GLS time-scale m^3*s/kg nojac(1/max(2 * rho_chns * 
sqrt(emetric_ale(u-rt,v-zt)),48 * 
eta_chns/h_ale^2)) 
tauc_chns GLS time-scale m^2/s 0.5 * nojac(if((u-rt)^2+(v-zt)^2<="" 
td=""> 
res_p_chns Equation residual 
for p 
kg/(m^2*s) rho_chns * r * divU_chns 
 
11.3.2. Subdomain 2 
 
Name Description Unit Expression 
RFR_axi Reaction force 
R-dir. 
N if(R>0,2 * reacf(uor) * pi/R,0) 
RFZ_axi Reaction force 
Z-dir. 
N 2 * reacf(w) * pi 
FRg_axi Body load in 
global R-dir. 
N/m^3 0 
FZg_axi Body load in 
global Z-dir. 
N/m^3 0 
disp_axi Total 
displacement 
M sqrt(real(uaxi_axi)^2+real(w)^2) 
uaxi_axi R-displacement M uor * R 
uaxiR_axi R derivative of 
R-displacement 
1 uorR * R+uor 
uaxiZ_axi Z derivative of 1 uorZ * R 
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R displacement 
uaxi_t_axi R-velocity m/s uort * R 
uaxi_tt_axi R-acceleration m/s^2 uortt * R 
sR_axi sR normal 
stress global 
sys. 
Pa E_axi * ((1-nu_axi) * eR_axi+nu_axi * 
ePHI_axi+nu_axi * eZ_axi)/((1+nu_axi) * (1-
2 * nu_axi)) 
sZ_axi sZ normal 
stress global 
sys. 
Pa E_axi * (nu_axi * eR_axi+nu_axi * 
ePHI_axi+(1-nu_axi) * eZ_axi)/((1+nu_axi) * 
(1-2 * nu_axi)) 
sPHI_axi sPHI normal 
stress 
Pa E_axi * (nu_axi * eR_axi+(1-nu_axi) * 
ePHI_axi+nu_axi * eZ_axi)/((1+nu_axi) * (1-
2 * nu_axi)) 
sRZ_axi sRZ shear stress 
global sys. 
Pa E_axi * eRZ_axi/(1+nu_axi) 
eR_axi eR normal 
strain global 
sys. 
1 uorR * R+uor 
eZ_axi eZ normal 
strain global 
sys. 
1 wZ 
ePHI_axi ePHI normal 
strain 
1 uor 
eRZ_axi eRZ shear 
strain global 
sys. 
1 0.5 * (uorZ * R+wR) 
sr_t_axi Time der. of 
normal stress 
global sys. (sR) 
Pa/s E_axi * ((1-nu_axi) * er_t_axi+nu_axi * 
ephi_t_axi+nu_axi * ez_t_axi)/((1+nu_axi) * 
(1-2 * nu_axi)) 
sz_t_axi Time der. of 
normal stress 
global sys. (sZ) 
Pa/s E_axi * (nu_axi * er_t_axi+nu_axi * 
ephi_t_axi+(1-nu_axi) * 
ez_t_axi)/((1+nu_axi) * (1-2 * nu_axi)) 
sphi_t_axi Time der. of 
normal stress 
(sPHI) 
Pa/s E_axi * (nu_axi * er_t_axi+(1-nu_axi) * 
ephi_t_axi+nu_axi * ez_t_axi)/((1+nu_axi) * 
(1-2 * nu_axi)) 
srz_t_axi Time der. of 
shear stress 
global sys. 
(sRZ) 
Pa/s E_axi * erz_t_axi/(1+nu_axi) 
er_t_axi eR_t normal 
velocity strain 
global sys. 
1/s uorRt * R+uort 
ez_t_axi eZ_t normal 1/s wZt 
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velocity strain 
global sys. 
ephi_t_axi ePHI_t normal 
velocity strain 
1/s uort 
erz_t_axi eRPHI_t shear 
velocity strain 
global sys. 
1/s 0.5 * (uorZt * R+wRt) 
mises_axi von Mises 
stress 
Pa sqrt(sR_axi^2+sPHI_axi^2+sZ_axi^2-sR_axi 
* sPHI_axi-sPHI_axi * sZ_axi-sR_axi * 
sZ_axi+3 * sRZ_axi^2) 
Ws_axi Strain energy 
density 
J/m^3 0.5 * (eR_axi * sR_axi+ePHI_axi * 
sPHI_axi+eZ_axi * sZ_axi+2 * eRZ_axi * 
sRZ_axi) 
evol_axi Volumetric 
strain 
1 eR_axi+ePHI_axi+eZ_axi 
tresca_axi Tresca stress Pa max(max(abs(s1_axi-s2_axi),abs(s2_axi-
s3_axi)),abs(s1_axi-s3_axi)) 
rinit_ale r coordinate 
initial value 
M R 
zinit_ale z coordinate 
initial value 
M Z 
dr_ale r-displacement M r-R 
dz_ale z-displacement M z-Z 
U_chns Velocity field m/s   
V_chns Vorticity 1/s   
divU_chns Divergence of 
velocity field 
1/s   
sr_chns Shear rate 1/s   
cellRe_chns Cell Reynolds 
number 
1   
res_u_chns Equation 
residual for u 
Pa   
res_v_chns Equation 
residual for v 
Pa   
beta_r_chns Convective 
field, r 
component 
Pa*s   
beta_z_chns Convective 
field, z 
component 
Pa*s   
Dm_chns Mean diffusion kg/s   
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coefficient 
da_chns Total time scale 
factor 
kg/m^2   
taum_chns GLS time-scale m^3*s/kg   
tauc_chns GLS time-scale m^2/s   
res_p_chns Equation 
residual for p 
kg/(m^2*s)   
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ABSTRACT 
NOVEL PULSATILE CARDIAC ASSIST PUMP 
by 
LAKSHMI MOHANADAS 
May 2015 
Advisor: Dr. Gregory W Auner 
Major: Biomedical Engineering 
Degree: Master of Science 
The project involve the research  and development of a pulsatile, complex or 
continuous flow in biological and non-biological systems implantable heart assist pump. 
Specifically as a 20% cardiac assist for persons from congestive heart failure and other 
cardiac abnormalities. The pulsatile cardiac assist pump would provide upto 20% of the 
blood pumping process from the venous supply to the arterial supply. Current pumps are 
largely complete bypass pumps or large volume  pumps that produce significant long term 
blood cell damage resulting in thrombosis. Most are not pulsatile which offers a significant 
physiological advantage. The pump under development is designed to prevent thrombosis by 
utilizing a unique geometry and pumping actuation mechanism. As part of the research we 
first used COSMOL simulation to aid in the design and blood flow dynamics. From these 
results we have designed a working prototype that can be configured in a number of 
geometries or stages. This design utilizes biocompatible material, Polyethylene oxide (PEO), 
which minimized protein interaction with the interior pumping surface. Shape memory alloy 
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actuators compress the pumping chamber. Shape memory alloy actuators also actuate 
compression of the ingoing sphincter valve and outgoing sphincter valves. Pumping motion 
can be analyzed by accelerometers to provide optimized feedback and pump motion control. 
Zoned compression may allow optimal compression for blood flow. This type of pumping 
system biomimics actual heart  compression and pulsation while the sphincter like valves 
minimizes thrombosis causing turbulent. A second actuation method may be employed 
utilizing pneumatic cuffs that inflate and compress the pump body and sphincter valves. The 
pump has a minimum of one hundred twenty mmHg pressure capabilities at fifty to one 
hundred and fifty beats per minute or in coordination with the compression and 
decompression rate of the heart as measured by blood pressure sensors or direct heart electro 
cardiac sensing. A cluster of pumps each independently controlled may be packaged for 
sequence or sequential actuation providing complex pumping and flow  patterns or 
continuous pumping flow. Further the pumps may be independently actuated in a tandem 
configuration. As such the pump provides a broad field of use including but not limited to 
arterial to arterial pumping, drug delivery, physiological fluidic maintenance, intravenous 
delivery, pressure maintenance and drug manufacturing where low turbulence flow is 
required and any pulsatile, complex flow pattern or continuous flow pattern is required.
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